Eligibility Prostate Cancer NCT00702923

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
at least 18 years of age & histologic diagnosis of adenocarcinoma of the prostate
Beschreibung

Age | Adenocarcinoma of prostate

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0007112
completed surgery or radiation at least 8 weeks prior to entry with removal of all visible disease
Beschreibung

Operative Surgical Procedures Completed | Therapeutic radiology procedure Completed | Excision Disease Visible

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0205197
UMLS CUI [3,1]
C0728940
UMLS CUI [3,2]
C0012634
UMLS CUI [3,3]
C0205379
clinical stage d0 prostate cancer with rising psa and psa >2ng/ml.
Beschreibung

Prostate carcinoma Clinical stage | Raised prostate specific antigen | Prostate specific antigen measurement

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0600139
UMLS CUI [1,2]
C0205563
UMLS CUI [2]
C0178415
UMLS CUI [3]
C0201544
ecog performance of <2
Beschreibung

ECOG performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
normal hematologic, renal and liver function
Beschreibung

Hematologic function | Renal function | Liver function

Datentyp

boolean

Alias
UMLS CUI [1]
C0221130
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
cannot have evidence of immunosuppression or have been treated with immunosuppressive therapy.
Beschreibung

Immunosuppression | Therapeutic immunosuppression

Datentyp

boolean

Alias
UMLS CUI [1]
C4048329
UMLS CUI [2]
C0021079
no prior treatment with an lhrh agonist or nonsteroidal antiandrogen such as casodex or flutamide
Beschreibung

Luteinizing Hormone-releasing Hormone Agonist | Nonsteroidal Anti-Androgens | Casodex | Flutamide

Datentyp

boolean

Alias
UMLS CUI [1]
C1518041
UMLS CUI [2]
C1320169
UMLS CUI [3]
C0591237
UMLS CUI [4]
C0016384
no evidence for metastatic disease per bone scan or ct scan of the abdomen and pelvis
Beschreibung

Neoplasm Metastasis Bone scan | Neoplasm Metastasis CT of abdomen and pelvis

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0203668
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C1641132
no prior treatment with anti-ctla 4 monoclonal antibody
Beschreibung

Anti-CTLA-4 Monoclonal Antibody

Datentyp

boolean

Alias
UMLS CUI [1]
C4289973
no history of known autoimmune disorder or hiv, hepatitis b or hepatitis c
Beschreibung

Autoimmune Disease | HIV Infection | Hepatitis B | Hepatitis C

Datentyp

boolean

Alias
UMLS CUI [1]
C0004364
UMLS CUI [2]
C0019693
UMLS CUI [3]
C0019163
UMLS CUI [4]
C0019196
no known brain metastases
Beschreibung

Metastatic malignant neoplasm to brain

Datentyp

boolean

Alias
UMLS CUI [1]
C0220650
no history of inflammatory bowel conditions including diverticulitis, ulcerative colitis, etc.
Beschreibung

Inflammatory Bowel Diseases | Diverticulitis | Ulcerative Colitis

Datentyp

boolean

Alias
UMLS CUI [1]
C0021390
UMLS CUI [2]
C0012813
UMLS CUI [3]
C0009324

Ähnliche Modelle

Eligibility Prostate Cancer NCT00702923

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Age | Adenocarcinoma of prostate
Item
at least 18 years of age & histologic diagnosis of adenocarcinoma of the prostate
boolean
C0001779 (UMLS CUI [1])
C0007112 (UMLS CUI [2])
Operative Surgical Procedures Completed | Therapeutic radiology procedure Completed | Excision Disease Visible
Item
completed surgery or radiation at least 8 weeks prior to entry with removal of all visible disease
boolean
C0543467 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C1522449 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
C0728940 (UMLS CUI [3,1])
C0012634 (UMLS CUI [3,2])
C0205379 (UMLS CUI [3,3])
Prostate carcinoma Clinical stage | Raised prostate specific antigen | Prostate specific antigen measurement
Item
clinical stage d0 prostate cancer with rising psa and psa >2ng/ml.
boolean
C0600139 (UMLS CUI [1,1])
C0205563 (UMLS CUI [1,2])
C0178415 (UMLS CUI [2])
C0201544 (UMLS CUI [3])
ECOG performance status
Item
ecog performance of <2
boolean
C1520224 (UMLS CUI [1])
Hematologic function | Renal function | Liver function
Item
normal hematologic, renal and liver function
boolean
C0221130 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Immunosuppression | Therapeutic immunosuppression
Item
cannot have evidence of immunosuppression or have been treated with immunosuppressive therapy.
boolean
C4048329 (UMLS CUI [1])
C0021079 (UMLS CUI [2])
Luteinizing Hormone-releasing Hormone Agonist | Nonsteroidal Anti-Androgens | Casodex | Flutamide
Item
no prior treatment with an lhrh agonist or nonsteroidal antiandrogen such as casodex or flutamide
boolean
C1518041 (UMLS CUI [1])
C1320169 (UMLS CUI [2])
C0591237 (UMLS CUI [3])
C0016384 (UMLS CUI [4])
Neoplasm Metastasis Bone scan | Neoplasm Metastasis CT of abdomen and pelvis
Item
no evidence for metastatic disease per bone scan or ct scan of the abdomen and pelvis
boolean
C0027627 (UMLS CUI [1,1])
C0203668 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2,1])
C1641132 (UMLS CUI [2,2])
Anti-CTLA-4 Monoclonal Antibody
Item
no prior treatment with anti-ctla 4 monoclonal antibody
boolean
C4289973 (UMLS CUI [1])
Autoimmune Disease | HIV Infection | Hepatitis B | Hepatitis C
Item
no history of known autoimmune disorder or hiv, hepatitis b or hepatitis c
boolean
C0004364 (UMLS CUI [1])
C0019693 (UMLS CUI [2])
C0019163 (UMLS CUI [3])
C0019196 (UMLS CUI [4])
Metastatic malignant neoplasm to brain
Item
no known brain metastases
boolean
C0220650 (UMLS CUI [1])
Inflammatory Bowel Diseases | Diverticulitis | Ulcerative Colitis
Item
no history of inflammatory bowel conditions including diverticulitis, ulcerative colitis, etc.
boolean
C0021390 (UMLS CUI [1])
C0012813 (UMLS CUI [2])
C0009324 (UMLS CUI [3])